Expression of leucine aminopeptidase 3 (LAP3) correlates with prognosis and malignant development of human hepatocellular carcinoma (HCC)

International Journal of Clinical and Experimental Pathology

Volumn 7, Issue 7, 2014, Pages 3752-3762

  Tian, Si Yuan ^a   Chen, Shou Hua ^a   Shao, Bing Feng ^a   Cai, Hong Yu ^a   Zhou, Yuan ^a   Zhou, Yi Long ^a   Xu, Ai Bing ^a  

^a NANTONG TUMOR HOSPITAL   (China)

Author keywords

Hepatocellular carcinoma (HCC); LAP3; Migration; Prognosis; Proliferation

Indexed keywords

CYTOSOL AMINOPEPTIDASE; LAP3 PROTEIN, HUMAN; TUMOR MARKER;

ADULT; AGED; BIOSYNTHESIS; ENZYMOLOGY; FEMALE; FLOW CYTOMETRY; GENETIC TRANSFECTION; HUMAN; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; LIVER TUMOR; MALE; MIDDLE AGED; PATHOLOGY; PROGNOSIS; TUMOR INVASION; UPREGULATION; WESTERN BLOTTING;

ADULT; AGED; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; LEUCYL AMINOPEPTIDASE; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PROGNOSIS; TRANSFECTION; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 84906249071     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Zhou P, Wu LL, Wu KM, Jiang W, Li JD, Zhou LD, Li XY, Chang S, Huang Y, Tan H, Zhang GW, He F and Wang ZM. Overexpression of MMSET is correlation with poor prognosis in hepatocellular carcinoma. Pathol Oncol Res 2013; 19: 303-309.
2. Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90.
3. de Lope CR, Tremosini S, Forner A, Reig M and Bruix J. Management of HCC. J Hepatol 2012; 56 Suppl 1: S75-87.
4. Malumbres M and Barbacid M. Cell cycle, CDKs and cancer: a changing paradigm. Nat Rev Cancer 2009; 9: 153-166.
5. Coleman WB. Mechanisms of human hepatocarcinogenesis. Curr Mol Med 2003; 3: 573-588.
6. Huang H, Tanaka H, Hammock BD and Morisseau C. Novel and highly sensitive fluorescent assay for leucine aminopeptidases. Anal Biochem 2009; 391: 11-16.
7. Tsujimoto M, Goto Y, Maruyama M and Hattori A. Biochemical and enzymatic properties of the M1 family of aminopeptidases involved in the regulation of blood pressure. Heart Fail Rev 2008; 13: 285-291.
8. Mizutani S, Shibata K, Kikkawa F, Hattori A, Tsujimoto M, Ishii M and Kobayashi H. Essential role of placental leucine aminopeptidase in gynecologic malignancy. Expert Opin Ther Targets 2007; 11: 453-461.
9. Shibata K, Kikkawa F, Mizokami Y, Kajiyama H, Ino K, Nomura S and Mizutani S. Possible involvement of adipocyte-derived leucine aminopeptidase via angiotensin II in endometrial carcinoma. Tumour Biol 2005; 26: 9-16.
10. Pilar Carrera M, Ramirez-Exposito MJ, Duenas B, Dolores Mayas M, Jesus Garcia M, De la Chica S, Cortes P, Ruiz-Sanjuan M and Martinez-Martos JM. Insulin-regulated aminopeptidase/ placental leucil Aminopeptidase (IRAP/P-lAP) and angiotensin IV-forming activities are modified in serum of rats with breast cancer induced by N-methyl-nitrosourea. Anticancer Res 2006; 26: 1011-1014.
11. Zhang S, Yang X, Shi H, Li M, Xue Q, Ren H, Yao L, Chen X, Zhang J and Wang H. Overexpression of leucine aminopeptidase 3 contributes to malignant development of human esophageal squamous cell carcinoma. J Mol Histol 2014; 45: 283-292.
12. Keller SR, Scott HM, Mastick CC, Aebersold R and Lienhard GE. Cloning and characterization of a novel insulin-regulated membrane aminopeptidase from Glut4 vesicles. J Biol Chem 1995; 270: 23612-23618.
13. Keller SR. Role of the insulin-regulated aminopeptidase IRAP in insulin action and diabetes. Biol Pharm Bull 2004; 27: 761-764.
14. Liu W, Jiang F, Bi X and Zhang YQ. Drosophila FMRP participates in the DNA damage response by regulating G2/M cell cycle checkpoint and apoptosis. Hum Mol Genet 2012; 21: 4655-4668.
15. Essers J, Theil AF, Baldeyron C, van Cappellen WA, Houtsmuller AB, Kanaar R and Vermeulen W. Nuclear dynamics of PCNA in DNA replication and repair. Mol Cell Biol 2005; 25: 9350-9359.
16. Oka H, Shiozaki H, Kobayashi K, Tahara H, Kobayashi T, Takatsuka Y and Mori T. [Correlation between E-cadherin expression and metastasis in human breast cancer: preliminary report]. Nihon Geka Gakkai Zasshi 1992; 93: 105.
17. Li Z, Tu M, Han B, Gu Y, Xue X, Sun J, Ge Q, Miao Y, Qian Z and Gao W. Vasohibin 2 decreases the cisplatin sensitivity of hepatocarcinoma cell line by downregulating p53. PLoS One 2014; 9: e90358.
18. Qin J, Luo M, Qian H and Chen W. Upregulated miR-182 increases drug resistance in cisplatin-treated HCC cell by regulating TP53INP1. Gene 2014; 538: 342-347.
19. Liu Y, Cui X, Hu B, Lu C, Huang X, Cai J, He S, Lv L, Cong X, Liu G, Zhang Y and Ni R. Upregulated expression of CAP1 is associated with tumor migration and metastasis in hepatocellular carcinoma. Pathol Res Pract 2014; 210: 169-175.
20. Wang XM, Yang LY, Guo L, Fan C and Wu F. p53-induced RING-H2 protein, a novel marker for poor survival in hepatocellular carcinoma after hepatic resection. Cancer 2009; 115: 4554-4563.
21. Makuuchi M, Imamura H, Sugawara Y and Takayama T. Progress in surgical treatment of hepatocellular carcinoma. Oncology 2002; 62 Suppl 1: 74-81.
22. Huang X, Qian X, Cheng C, He S, Sun L, Ke Q, Zhang L, Pan X, He F, Wang Q, Meng J, Ni R and Shen A. Expression of Pirh2, a p27 (Kip1) ubiquitin ligase, in hepatocellular carcinoma: correlation with p27 (Kip1) and cell proliferation. Hum Pathol 2011; 42: 507-515.
23. Hung JH, Lu YS, Wang YC, Ma YH, Wang DS, Kulp SK, Muthusamy N, Byrd JC, Cheng AL and Chen CS. FTY720 induces apoptosis in hepatocellular carcinoma cells through activation of protein kinase C delta signaling. Cancer Res 2008; 68: 1204-1212.
24. Vijayachandra K, Higgins W, Lee J and Glick A. Induction of p16ink4a and p19ARF by TGFbeta1 contributes to growth arrest and senescence response in mouse keratinocytes. Mol Carcinog 2009; 48: 181-186.
25. Yamazaki T, Akada T, Niizeki O, Suzuki T, Miyashita H and Sato Y. Puromycin-insensitive leucyl-specific aminopeptidase (PILSAP) binds and catalyzes PDK1, allowing VEGF-stimulated activation of S6K for endothelial cell proliferation and angiogenesis. Blood 2004; 104: 2345-2352.
26. Tripathi V, Shen Z, Chakraborty A, Giri S, Freier SM, Wu X, Zhang Y, Gorospe M, Prasanth SG, Lal A and Prasanth KV. Long noncoding RNA MALAT1 controls cell cycle progression by regulating the expression of oncogenic transcription factor B-MYB. PLoS Genet 2013; 9: e1003368.
27. van den Heuvel S. Cell-cycle regulation. WormBook 2005; 1-16.
28. Zhai X, Zhu H, Wang W, Zhang S, Zhang Y and Mao G. Abnormal expression of EMT-related proteins, S100A4, vimentin and E-cadherin, is correlated with clinicopathological features and prognosis in HCC. Med Oncol 2014; 31: 970.
29. Hong JY, Kim GH, Kim JW, Kwon SS, Sato EF, Cho KH and Shim EB. Computational modeling of apoptotic signaling pathways induced by cisplatin. BMC Syst Biol 2012; 6: 122.
30. McIlwain DR, Berger T and Mak TW. Caspase functions in cell death and disease. Cold Spring Harb Perspect Biol 2013; 5: a008656.